PTC Therapeutics
PTCT
#2771
Rank
HK$49.89 B
Marketcap
HK$601.45
Share price
2.17%
Change (1 day)
47.73%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: HK$49.89 Billion

As of June 2026 PTC Therapeutics has a market cap of HK$49.89 Billion. This makes PTC Therapeutics the world's 2771th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$49.89 B1.66%
2025HK$49.07 B81.21%
2024HK$27.08 B66.73%
2023HK$16.24 B-25.37%
2022HK$21.76 B-0.88%
2021HK$21.95 B-31.99%
2020HK$32.28 B39.35%
2019HK$23.16 B70.34%
2018HK$13.60 B151.54%
2017HK$5.40 B86.23%
2016HK$2.90 B-65.91%
2015HK$8.51 B-35.53%
2014HK$13.21 B321.75%
2013HK$3.13 B

End of Day market cap according to different sources

On Jun 14th, 2026 the market cap of PTC Therapeutics was reported to be:

HK$48.83 Billion
by Nasdaq info icon info icon
HK$48.83 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
HK$2.265 T 4,441.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
HK$895.71 B 1,695.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$7.09 B-85.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$13.04 B-73.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$1.83 B-96.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$88.13 B 76.65%๐Ÿ‡บ๐Ÿ‡ธ USA